<DOC>
	<DOCNO>NCT02929095</DOCNO>
	<brief_summary>Percutaneous trans-arterial angioplasty ( PTA ) one peripheral arterial occlusive disease ( PAOD ) treatment . During PTA , ischemia-reperfusion pain induce proper analgesia important . ischemia-reperfusion injury due reactive oxygen specie . Dexmedetomidine analgesic , sedative anti oxidant effect . So investigators research patient 's satisfaction give dexmedetomidine PTA procedure .</brief_summary>
	<brief_title>The Effect Remifentanil-dexmedetomidine Compared With Remifentanil-midazolam Patient 's Satisfaction</brief_title>
	<detailed_description />
	<mesh_term>Arterial Occlusive Diseases</mesh_term>
	<mesh_term>Peripheral Arterial Disease</mesh_term>
	<mesh_term>Dexmedetomidine</mesh_term>
	<mesh_term>Remifentanil</mesh_term>
	<mesh_term>Midazolam</mesh_term>
	<criteria>patient schedule undergo percutaneous transarterial angioplasty American Society Anesthesiologists ( ASA ) class I , II , III Subjects ineligible condition psychiatric medication myocardial infarction within 1 year cardiac surgery within 1 year heart failure fever ( &gt; 38 degree ) uncontrolled hypertension cognitive dysfunction disable mental change disorder unable communicate speak Korean</criteria>
	<gender>Male</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>79 Years</maximum_age>
	<verification_date>October 2016</verification_date>
</DOC>